<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet href="https://www.accessdata.fda.gov/spl/stylesheet/spl.xsl" type="text/xsl"?>
<document xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="urn:hl7-org:v3 https://www.accessdata.fda.gov/spl/schema/spl.xsd">
   <id root="ddce307a-e12a-4731-b334-54185ed76426"/>
   <code code="50577-6" codeSystem="2.16.840.1.113883.6.1" displayName="OTC ANIMAL DRUG LABEL"/>
   <effectiveTime value="20220817"/>
   <setId root="49ded0a0-a4d9-4715-bb2b-2e5d92bceabf"/>
   <versionNumber value="4"/>
   <author>
      <time/>
      <assignedEntity>
         <representedOrganization>
            <id extension="261126049" root="1.3.6.1.4.1.519.1"/>
            <name>Ceva Santé Animale</name>
            <assignedEntity>
               <assignedOrganization>
                  <assignedEntity>
                     <assignedOrganization>
                        <id root="1.3.6.1.4.1.519.1" extension="117877975"/>
                        <name>Alcami Carolinas Corporation</name>
                     </assignedOrganization>
                     <performance>
                        <actDefinition>
                           <code code="C25391" displayName="analysis" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                        </actDefinition>
                     </performance>
                  </assignedEntity>
               </assignedOrganization>
            </assignedEntity>
         </representedOrganization>
      </assignedEntity>
   </author>
   <component>
      <structuredBody>
         <component>
            <section>
               <id root="b10c46a8-7240-414e-ac2f-9e137a8bf3aa"/>
               <code code="48780-1" codeSystem="2.16.840.1.113883.6.1" displayName="SPL product data elements section"/>
               <effectiveTime value="20160203"/>
               <subject>
                  <manufacturedProduct>
                     <manufacturedProduct>
                        <code code="13744-520" codeSystem="2.16.840.1.113883.6.69"/>
                        <name>ChronoMate</name>
                        <formCode code="C42986" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="SOLUTION"/>
                        <asEntityWithGeneric>
                           <genericMedicine>
                              <name>Altrenogest</name>
                           </genericMedicine>
                        </asEntityWithGeneric>
                        <ingredient classCode="ACTIB">
                           <quantity>
                              <numerator unit="mg" value="2.2"/>
                              <denominator unit="mL" value="1"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="2U0X0JA2NB" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>ALTRENOGEST</name>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="2U0X0JA2NB" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>ALTRENOGEST</name>
                                 </activeMoiety>
                              </activeMoiety>
                           </ingredientSubstance>
                        </ingredient>
                        <asContent>
                           <quantity>
                              <numerator unit="mL" value="1000"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code code="13744-520-10" codeSystem="2.16.840.1.113883.6.69"/>
                              <formCode code="C43169" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BOTTLE"/>
                           </containerPackagedProduct>
                        </asContent>
                     </manufacturedProduct>
                     <subjectOf>
                        <approval>
                           <id extension="ANADA200579" root="2.16.840.1.113883.3.150"/>
                           <code code="C73583" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="ANADA"/>
                           <author>
                              <territorialAuthority>
                                 <territory>
                                    <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                 </territory>
                              </territorialAuthority>
                           </author>
                        </approval>
                     </subjectOf>
                     <subjectOf>
                        <marketingAct>
                           <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <statusCode code="active"/>
                           <effectiveTime>
                              <low value="20160118"/>
                           </effectiveTime>
                        </marketingAct>
                     </subjectOf>
                     <subjectOf>
                        <characteristic classCode="OBS">
                           <code code="SPLCOLOR" codeSystem="2.16.840.1.113883.1.11.19255"/>
                           <value code="C48330" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="YELLOW" xsi:type="CE">
                              <originalText>Light</originalText>
                           </value>
                        </characteristic>
                     </subjectOf>
                     <consumedIn>
                        <substanceAdministration>
                           <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="ORAL"/>
                        </substanceAdministration>
                     </consumedIn>
                  </manufacturedProduct>
               </subject>
            </section>
         </component>
         <component>
            <section ID="i4i_description_id_c201844a-4d21-4745-bd0a-079140213d2b">
               <id root="c432929c-28b9-4d68-b6ff-98dc3b04c6ed"/>
               <code code="34089-3" codeSystem="2.16.840.1.113883.6.1" displayName="DESCRIPTION SECTION"/>
               <text>
                  <paragraph>
                     <content styleCode="bold">ChronoMate™</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">(altrenogest)</content>
                  </paragraph>
                  <paragraph>SOLUTION 0.22%</paragraph>
                  <paragraph>(2.2 mg/mL)</paragraph>
                  <paragraph>
                     <content styleCode="bold">FOR ORAL USE IN ANIMALS ONLY</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Drug Facts:</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Active ingredients:</content> Altrenogest Solution 0.22% (2.2 mg/mL)</paragraph>
                  <paragraph>
                     <content styleCode="bold">Use:</content> For synchronization of estrus in sexually mature gilts that have had at least one estrous cycle. Treatment with altrenogest solution 0.22% results in estrus (standing heat) 4 to 9 days after completion of the 14-day treatment period.</paragraph>
                  <paragraph>
                     <content styleCode="bold">Caution:</content> Federal law prohibits extra-label use of this drug to enhance food and/or fiber production in animals.</paragraph>
                  <paragraph>
                     <content styleCode="bold">Do Not Use:</content> In gilts having a previous or current history of uterine inflammation (i.e., acute, subacute or chronic endometritis).</paragraph>
               </text>
               <effectiveTime value="20160112"/>
            </section>
         </component>
         <component>
            <section ID="L6f44d11e-7e81-4907-8121-a92b7850f662">
               <id root="7702d0b1-e1b2-4f01-8646-2f8d0468674f"/>
               <code code="34071-1" codeSystem="2.16.840.1.113883.6.1" displayName="WARNINGS SECTION"/>
               <title>WARNINGS</title>
               <text>
                  <paragraph>
                     <content styleCode="bold">Keep this and all medication out of the </content>
                     <content styleCode="bold">reach of children.</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">User/Handler Safety:</content> Avoid skin contact. Wear vinyl, neoprene or nitrile protective gloves when handling this product. <content styleCode="bold">DO NOT USE LATEX GLOVES</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="underline">Pregnant women or women who suspect they are pregnant should not handle ChronoMate (altrenogest) solution 0.22%.</content> Women of childbearing age should exercise extreme caution when handling this product. Accidental absorption could lead to a disruption of the menstrual cycle or prolongation of pregnancy. Wash off accidental spillage on the skin immediately with soap and water.</paragraph>
                  <paragraph>
                     <content styleCode="bold">People who should not handle this product:</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">1.</content> Women who are or suspect they are pregnant.</paragraph>
                  <paragraph>
                     <content styleCode="bold">2.</content> Anyone with thrombophlebitis or thromboembolic disorders or with a history of these events.</paragraph>
                  <paragraph>
                     <content styleCode="bold">3.</content> Anyone with cerebral-vascular or coronary-artery disease.</paragraph>
                  <paragraph>
                     <content styleCode="bold">4.</content> Women with known or suspected carcinoma of the breast.</paragraph>
                  <paragraph>
                     <content styleCode="bold">5.</content> People with known or suspected estrogen-dependent neoplasia.</paragraph>
                  <paragraph>
                     <content styleCode="bold">6.</content> Women with undiagnosed vaginal bleeding.</paragraph>
                  <paragraph>
                     <content styleCode="bold">7.</content> People with benign or malignant tumors which developed during the use of oral contraceptives or other estrogen-containing products.</paragraph>
                  <paragraph>
                     <content styleCode="bold">8.</content> Anyone with liver dysfunction or disease.</paragraph>
                  <paragraph>
                     <content styleCode="bold">Accidental exposure:</content> Altrenogest is readily absorbed from contact with the skin. In addition, this oil based product can penetrate porous gloves. Altrenogest should not penetrate <content styleCode="underline">intact</content> vinyl, neoprene or nitrile protective gloves; however, if there is leakage (i.e., pinhole, spillage, etc.) the contaminated area covered by such occlusive materials may have increased absorption. <content styleCode="bold">DO NOT USE LATEX GLOVES</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">The following measures are recommended in case of accidental exposure.</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="underline">
                        <content styleCode="bold">Skin Exposure:</content>
                     </content> Wash immediately with soap and water.</paragraph>
                  <paragraph>
                     <content styleCode="underline">
                        <content styleCode="bold">Eye Exposure:</content>
                     </content> Immediately flush with plenty of water for 15 minutes. Get medical attention.</paragraph>
                  <paragraph>
                     <content styleCode="underline">
                        <content styleCode="bold">If Swallowed:</content>
                     </content>Do not induce vomiting. ChronoMate (altrenogest) solution 0.22% contains an oil. Call a physician. Vomiting should be supervised by a physician because of possible pulmonary damage via aspiration of the oil base. If possible, bring the container and labeling to the physician.</paragraph>
                  <paragraph>
                     <content styleCode="bold">Effects of Overexposure:</content> There has been no human use of this specific product. The information contained in this section is extrapolated from data available on other products of the same pharmacological class that have been used in humans. Effects anticipated are due to the progestational activity of altrenogest. Acute effects after a single exposure are possible; however, continued daily exposure has the potential for more untoward effects such as disruption of the menstrual cycle, uterine or abdominal cramping, increased or decreased uterine bleeding, prolongation of pregnancy and headaches. The oil base may also cause complications if swallowed. In addition, the list of people who should not handle this product is based upon the known effects of progestins used in humans on a chronic basis.</paragraph>
               </text>
               <effectiveTime value="20160114"/>
            </section>
         </component>
         <component>
            <section ID="Le5ad3751-39d6-4ef2-bde6-0bf50329d73d">
               <id root="6194c2d9-d4db-4187-8fef-08a9988046f3"/>
               <code code="50743-4" codeSystem="2.16.840.1.113883.6.1" displayName="FOOD SAFETY WARNING SECTION"/>
               <text>
                  <paragraph>
                     <content styleCode="bold">Human Food Safety: </content>Gilts must not be slaughtered for human consumption for 21 days after the last treatment.</paragraph>
               </text>
               <effectiveTime value="20150508"/>
            </section>
         </component>
         <component>
            <section ID="L9e9c3850-1cb2-43b3-ba36-40401018c5d8">
               <id root="7599db92-77d4-46f2-a1b9-30ce3a85421f"/>
               <code code="50742-6" codeSystem="2.16.840.1.113883.6.1" displayName="ENVIRONMENTAL WARNING SECTION"/>
               <text>
                  <paragraph>
                     <content styleCode="bold">Environmental Safety:</content> Place empty drug containers and used syringes, protective gloves or other articles that come in contact with this product in a leak-resistant container for disposal in accordance with applicable Federal, state and local regulations.</paragraph>
               </text>
               <effectiveTime value="20150508"/>
            </section>
         </component>
         <component>
            <section ID="Ldca2d329-4a3f-4c9d-b8db-907cb24fe5a3">
               <id root="ac098484-c1c5-4365-87ea-0a4ffa5b7fa5"/>
               <code code="34084-4" codeSystem="2.16.840.1.113883.6.1" displayName="ADVERSE REACTIONS SECTION"/>
               <text>
                  <paragraph>
                     <content styleCode="bold">Adverse Reactions and Potential Safety Hazards:</content> Underfeeding of ChronoMate may lead to the occurrence of cystic follicles.</paragraph>
                  <paragraph>
                     <content styleCode="bold">When Using This Product:</content> A small percentage (less than 5%) of treated gilts may exhibit estrus (standing heat) during the 14-day treatment period. Gilts nearing estrus at the start of the 14-day treatment period may express estrus early in that period.</paragraph>
               </text>
               <effectiveTime value="20160114"/>
            </section>
         </component>
         <component>
            <section ID="i4i_indications_id_8d33ac34-f932-41e0-aa7d-465368c35560">
               <id root="2d70ede7-36d6-461e-9794-ca383fed2c3d"/>
               <code code="34068-7" codeSystem="2.16.840.1.113883.6.1" displayName="DOSAGE &amp; ADMINISTRATION SECTION"/>
               <text>
                  <paragraph>
                     <content styleCode="bold">Dosage and Directions:</content> While wearing protective gloves, remove shipping cap and seal; replace with enclosed plastic dispensing cap. Remove cover from bottle dispensing tip and connect luer lock syringe (without needle). Draw out appropriate volume of ChronoMate. (Note: Do not remove syringe while bottle is inverted as spillage may result.) Detach syringe and replace cover on bottle dispensing tip to prevent leakage. Administer 6.8 mL (15 mg altrenogest) per gilt once daily for 14 consecutive days. Treat gilts on an individual animal basis by top-dressing ChronoMate on a portion of each gilt’s daily feed allowance. To produce the desired synchronization of estrus in a group of gilts, treat all of the gilts daily for the same 14-day period. Excessive use of a syringe may cause the syringe to stick; therefore, replace syringe as necessary.</paragraph>
               </text>
               <effectiveTime value="20160114"/>
            </section>
         </component>
         <component>
            <section ID="i4i_how_supplied_id_1d1eb32f-7309-4d30-bc57-cc8e989f2db4">
               <id root="832b66c9-45ca-4d13-bd9e-f8a9f8c2fadf"/>
               <code code="44425-7" codeSystem="2.16.840.1.113883.6.1" displayName="STORAGE AND HANDLING SECTION"/>
               <text>
                  <paragraph>
                     <content styleCode="bold">Other Information:</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Storage:</content> Store at or below room temperature, 77°F (25°C). Close tightly.</paragraph>
               </text>
               <effectiveTime value="20150508"/>
            </section>
         </component>
         <component>
            <section ID="Ld8d49b29-c9a1-48c3-8baa-c432367f8852">
               <id root="2e0d9d73-84f4-4fa9-8cda-d754383fa458"/>
               <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
               <text>
                  <paragraph>
                     <content styleCode="bold">Questions? Comments?</content>
                  </paragraph>
                  <paragraph>- To report a suspected adverse reaction, call 1-800-999-0297.</paragraph>
                  <paragraph>- To obtain product information, including material safety data sheet (MSDS), call 1-800-999-0297.</paragraph>
                  <paragraph>
                     <content styleCode="bold">Manufactured for:</content>
                  </paragraph>
                  <paragraph>Ceva Santé Animale, Libourne, France</paragraph>
                  <paragraph>
                     <content styleCode="bold">Marketed by:</content>
                  </paragraph>
                  <paragraph>Ceva Animal Health, LLC Lenexa, KS 66215</paragraph>
                  <paragraph>ANADA # 200-579, Approved by FDA</paragraph>
               </text>
               <effectiveTime value="20150512"/>
            </section>
         </component>
         <component>
            <section ID="i4i_Principal_display_panel_id_cbc7e1a9-35f7-4a92-b980-9da6815aee7e">
               <id root="6a25cae4-47d3-4d07-bf34-9a2b2561ec46"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>PRINCIPAL DISPLAY PANEL - 1000 mL BOTTLE</title>
               <text>
                  <paragraph>
                     <content styleCode="bold">ChronoMate™</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">(altrenogest)</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">FOR ORAL USE IN ANIMALS ONLY</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Drug Facts:</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Active ingredients:</content> Altrenogest Solution 0.22% (2.2 mg/mL)</paragraph>
                  <paragraph>
                     <content styleCode="bold">Use:</content> For synchronization of estrus in sexually mature gilts that have had at least one estrous cycle. Treatment with altrenogest solution 0.22% results in estrus (standing heat) 4 to 9 days after completion of the 14-day treatment period.</paragraph>
                  <paragraph>
                     <content styleCode="bold">Caution:</content> Federal law prohibits extra-label use of this drug to enhance food and/or fiber production in animals.</paragraph>
                  <paragraph>
                     <content styleCode="bold">Do Not Use:</content> In gilts having a previous or current history of uterine inflammation (i.e., acute, subacute or chronic endometritis).</paragraph>
                  <paragraph>
                     <content styleCode="bold">Net Contents: 1000 mL</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Restricted Drug (California) – use only as directed.</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Not for Human Use</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Keep this and all medication out of the reach of children.</content>
                  </paragraph>
                  <paragraph>
                     <renderMultiMedia referencedObject="L57ccc715-a6b1-487f-88ef-369586485c50"/>
                  </paragraph>
               </text>
               <effectiveTime value="20220817"/>
               <component>
                  <observationMedia ID="L57ccc715-a6b1-487f-88ef-369586485c50">
                     <text>1000 mL Bottle Label</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="1000mLBottle.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
      </structuredBody>
   </component>
</document>